查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748823

布洛芬市場－全球產業規模、佔有率、趨勢、機會和預測，按產品類型、應用、地區和競爭細分，2020-2030 年

Ibuprofen Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球布洛芬市值為 5.3445 億美元，預計到 2030 年將達到 7.0003 億美元，複合年成長率為 4.80%。布洛芬是一種廣泛使用的非類固醇抗發炎藥物 (NSAID)，因其價格低廉和在治療關節炎、經痛、牙齒問題和普通感冒等各個治療領域控制疼痛、發燒和發炎的有效性而得到認可。布洛芬有幾種劑型，如片劑、膠囊、糖漿和外用藥，其可近性使其成為處方藥和非處方藥的首選治療選擇。市場的成長是由慢性疼痛和與年齡相關的疾病發生率的增加所驅動，尤其是在老年人群中。隨著全球預期壽命的增加，對安全、可靠和具有成本效益的止痛藥的需求也在增加。製造業競爭非常激烈，許多全球和地區參與者都參與活性藥物成分 (API) 的生產和成品劑型的開發，從而形成了價格敏感的市場環境。

市場概覽
預測期 2026-2030
2024年市場規模 5.3445億美元
2030年市場規模 7.0003億美元
2025-2030 年複合年成長率 4.80%
成長最快的領域 藥片
最大的市場 北美洲

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

安全性和副作用問題

主要市場趨勢

電子藥房的擴展

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球布洛芬市場的影響

第5章：全球布洛芬市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品類型（片劑、膠囊、糖漿、注射）
    • 依用途分類（類風濕性關節炎、僵直性脊椎炎、發炎性疾病、經痛、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美布洛芬市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲布洛芬市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太布洛芬市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲布洛芬市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲布洛芬市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球布洛芬市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • Novartis AG
  • Pfizer Inc.
  • Abbott Laboratories Inc.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Astellas Pharma Inc.
  • Glenmark Pharmaceuticals Ltd.
  • NATCO Pharma Ltd.
  • Basilea Pharmaceutical AG
  • Leadiant Biosciences Inc.

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 7235

The Global Ibuprofen Market was valued at USD 534.45 Million in 2024 and is projected to reach USD 700.03 Million by 2030, growing at a CAGR of 4.80%. Ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID), is recognized for its affordability and effectiveness in managing pain, fever, and inflammation across various therapeutic areas including arthritis, menstrual cramps, dental issues, and the common cold. Available in several formulations such as tablets, capsules, syrups, and topical applications, ibuprofen's accessibility makes it a go-to treatment option for both prescription and over-the-counter use. The market's growth is driven by the increasing incidence of chronic pain and age-related disorders, particularly in the elderly population. As life expectancy rises globally, so does the demand for safe, reliable, and cost-effective analgesics. The manufacturing landscape is highly competitive, with numerous global and regional players engaged in both active pharmaceutical ingredient (API) production and finished dosage development, contributing to a price-sensitive market environment.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 534.45 Million
Market Size 2030USD 700.03 Million
CAGR 2025-20304.80%
Fastest Growing SegmentTablet
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The sustained expansion of the global healthcare industry is a key driver of the ibuprofen market. The U.S. alone spends nearly USD 3.5 trillion annually on healthcare, while healthcare expenditure in Europe comprises around 12% of GDP. In contrast, BRIC nations allocate an average of 6% of GDP to health services. This growing investment in healthcare infrastructure, combined with improved access to treatment and the increasing emphasis on affordable care, supports rising demand for over-the-counter and prescription medications like ibuprofen. Known for its anti-inflammatory, analgesic, and fever-reducing effects, ibuprofen remains a trusted first-line treatment option for mild to moderate pain and inflammatory conditions. Companies such as IOL Chemicals and Pharmaceuticals, which supplies about one-third of the global ibuprofen API, are expanding their product portfolios to meet growing demand fueled by the rising prevalence of lifestyle-related ailments like arthritis, chronic headaches, and musculoskeletal disorders.

Key Market Challenges

Safety & Side Effect Concerns

Despite its widespread usage and therapeutic benefits, ibuprofen faces notable challenges due to safety concerns and potential side effects. As an NSAID, ibuprofen is linked to gastrointestinal issues, particularly when used at high doses or over extended periods. Common side effects include stomach irritation, ulcers, and bleeding, which pose heightened risks for elderly patients or individuals with pre-existing GI conditions. In response, healthcare providers are increasingly recommending alternative treatments or co-prescribing gastroprotective agents to mitigate these risks. This shift in prescribing behavior could dampen demand for ibuprofen and encourage the use of other analgesic options, especially in vulnerable patient populations.

Key Market Trends

Expansion of E-Pharmacy

The growing prominence of e-pharmacy platforms is reshaping the global ibuprofen market by revolutionizing how medications are purchased and delivered. With digital transformation accelerating across the healthcare sector, online pharmacies are gaining traction as a preferred distribution channel for OTC medications like ibuprofen. Companies such as Amazon, Reliance, Tata 1mg, and PharmEasy are scaling operations in response to rising demand for convenience, competitive pricing, and timely access to medicines. In India, the e-pharmacy market was expected to expand sevenfold to USD 2.7 billion by 2023, reflecting broader shifts in consumer behavior and increased internet accessibility. This trend is enhancing market penetration, particularly in underserved regions, while also intensifying competition among digital pharmacy players seeking to dominate this growing segment.

Key Market Players

  • Novartis AG
  • Pfizer Inc.
  • Abbott Laboratories Inc.
  • Gilead Sciences Inc.
  • Merck KGaA
  • Astellas Pharma Inc.
  • Glenmark Pharmaceuticals Ltd.
  • NATCO Pharma Ltd.
  • Basilea Pharmaceutical AG
  • Leadiant Biosciences Inc.

Report Scope

In this report, the Global Ibuprofen Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ibuprofen Market, By Product Type:

  • Tablet
  • Capsule
  • Syrup
  • Injection

Ibuprofen Market, By Application:

  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Inflammatory Diseases
  • Dysmenorrhea
  • Others

Ibuprofen Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ibuprofen Market.

Available Customizations

Global Ibuprofen Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Ibuprofen Market

5. Global Ibuprofen Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Tablet, Capsule, Syrup, Injection)
    • 5.2.2. By Application (Rheumatoid Arthritis, Ankylosing Spondylitis, Inflammatory Diseases, Dysmenorrhea, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Ibuprofen Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ibuprofen Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Ibuprofen Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Ibuprofen Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Ibuprofen Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Ibuprofen Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Ibuprofen Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Ibuprofen Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Ibuprofen Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Ibuprofen Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Ibuprofen Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ibuprofen Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Ibuprofen Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Ibuprofen Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Ibuprofen Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Ibuprofen Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. South America Ibuprofen Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Ibuprofen Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Ibuprofen Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Ibuprofen Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Ibuprofen Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Ibuprofen Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Ibuprofen Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Ibuprofen Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Ibuprofen Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Novartis AG
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Pfizer Inc.
  • 16.3. Abbott Laboratories Inc.
  • 16.4. Gilead Sciences Inc.
  • 16.5. Merck KGaA
  • 16.6. Astellas Pharma Inc.
  • 16.7. Glenmark Pharmaceuticals Ltd.
  • 16.8. NATCO Pharma Ltd.
  • 16.9. Basilea Pharmaceutical AG
  • 16.10. Leadiant Biosciences Inc.

17. Strategic Recommendations

18. About Us & Disclaimer